Cancer Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Brain Cancer
Recent studies from University of Regensburg add new data to brain cancer
December 2nd, 2008
In this recent study, researchers in Regensburg, Germany conducted a study "To demonstrate the feasibility of a biologically adapted dose-escatation approach to brain tumors. Due to the specific accumulation of fluoroethyltyrosine (FET) in brain tumors, F-18-FET-PET imaging is used to derive a voxel-by-voxel dose distribution." "Although the kinetics of F-18-FET are not completely understood, the authors regard regions with high tracer uptake as vital and aggressive tumor and use a Linear dose-escalation function between SUV (standard uptake value) 3 and SUV 5. The resulting dose distribution is then planned using the inverse Monte Carlo treatment-planning system IKO....
Source: Cancer Weekly (2008-12-02)
|
